WallStreetZenWallStreetZen

NASDAQ: MDVL
Medavail Holdings Inc Stock

$0.37-0.01 (-2.63%)
Updated Feb 3, 2023
MDVL Price
$0.37
Fair Value Price
$0.71
Market Cap
$29.86M
52 Week Low
$0.24
52 Week High
$3.56
P/E
-0.34x
P/B
0.95x
P/S
1.59x
PEG
N/A
Dividend Yield
N/A
Revenue
$39.04M
Earnings
-$49.17M
Gross Margin
6%
Operating Margin
-123.06%
Profit Margin
-126%
Debt to Equity
0.59
Operating Cash Flow
-$52M
Beta
0.67
Next Earnings
Mar 28, 2023
Ex-Dividend
N/A
Next Dividend
N/A

MDVL Overview

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MDVL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MDVL ($0.37) is undervalued by 47.67% relative to our estimate of its Fair Value price of $0.71 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MDVL ($0.37) is significantly undervalued by 47.67% relative to our estimate of its Fair Value price of $0.71 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MDVL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MDVL due diligence checks available for Premium users.

Be the first to know about important MDVL news, forecast changes, insider trades & much more!

MDVL News

Valuation

MDVL fair value

Fair Value of MDVL stock based on Discounted Cash Flow (DCF)
Price
$0.37
Fair Value
$0.71
Undervalued by
48.09%
MDVL ($0.37) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDVL ($0.37) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MDVL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MDVL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.34x
Industry
18.24x
Market
15.09x

MDVL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.95x
Industry
1.9x
MDVL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MDVL's financial health

Profit margin

Revenue
$11.5M
Net Income
-$11.8M
Profit Margin
-103%
MDVL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MDVL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$49.9M
Liabilities
$18.5M
Debt to equity
0.59
MDVL's short-term assets ($39.40M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDVL's short-term assets ($39.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDVL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MDVL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.6M
Investing
-$171.0k
Financing
$9.7M
MDVL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MDVL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
MDVL$29.86M-1.84%-0.34x0.95x
ZYNE$29.65M+3.11%-0.72x0.56x
LCI$28.98M-1.03%-0.14x-0.09x
FLGC$31.49M+2.26%N/A0.58x
ADMP$33.00M-4.35%-1.00x11.60x

Medavail Holdings Stock FAQ

What is Medavail Holdings's quote symbol?

NASDAQ: MDVL) Medavail Holdings trades on the NASDAQ under the ticker symbol MDVL. Medavail Holdings stock quotes can also be displayed as NASDAQ: MDVL.

If you're new to stock investing, here's how to buy Medavail Holdings stock.

What is the 52 week high and low for Medavail Holdings (NASDAQ: MDVL)?

(NASDAQ: MDVL) Medavail Holdings's 52-week high was $3.56, and its 52-week low was $0.24. It is currently -89.52% from its 52-week high and 54.77% from its 52-week low.

How much is Medavail Holdings stock worth today?

(NASDAQ: MDVL) Medavail Holdings currently has 80,045,696 outstanding shares. With Medavail Holdings stock trading at $0.37 per share, the total value of Medavail Holdings stock (market capitalization) is $29.86M.

Medavail Holdings stock was originally listed at a price of $300.00 in Mar 4, 2011. If you had invested in Medavail Holdings stock at $300.00, your return over the last 11 years would have been -99.88%, for an annualized return of -45.57% (not including any dividends or dividend reinvestments).

How much is Medavail Holdings's stock price per share?

(NASDAQ: MDVL) Medavail Holdings stock price per share is $0.37 today (as of Feb 3, 2023).

What is Medavail Holdings's Market Cap?

(NASDAQ: MDVL) Medavail Holdings's market cap is $29.86M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medavail Holdings's market cap is calculated by multiplying MDVL's current stock price of $0.37 by MDVL's total outstanding shares of 80,045,696.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.